Review Article

The Value of Haematological Parameters and Tumour Markers in the Prediction of Intestinal Obstruction in 1474 Chinese Colorectal Cancer Patients

Table 2

Baseline Clinicopathologic Characteristics of colorectal cancer patients.

OCCNon-OCCP
(n =238) (%)(n =1236) (%)

Age(yr) (median ± qrange)59.00 ± 15.0058.50 ± 16.000.1162
SexMale148 (62.18)719 (58.17)0.2493
Female90 (37.82)517 (41.83)
SmokeNo176 (73.95)995 (80.50)0.0220
Yes62 (26.05)241 (19.50)
Tumor historyNo221 (92.86)1097 (88.75)0.0595
Yes17 (7.14)139 (11.25)
Tumor locationLeft colon129 (54.20)894 (72.33)<0.0001
Right colon109 (45.80)342 (27.67)
TNMI4 (1.68)193 (15.61)<0.0001
II95 (39.92)407 (32.93)
III106 (44.54)474 (38.35)
IV33 (13.87)162 (13.11)
Tumor size (cm)d <4.5105 (44.12)751 (60.76)<0.0001
4.5 ≤ d133 (55.88)485 (39.24)
DifferentiationLow25 (10.50)69 (5.58)0.0044
High213 (89.50)1167 (94.42)
Circumferential marginNo236 (99.17)1224 (99.03)0.8492
Yes2 (0.83)12 (0.97)
Vascular tumor thrombusNo187 (78.57)1022 (82.69)0.1301
Yes51 (21.43)214 (17.31)
Nerve invasionNo161 (70.17)988 (79.94)0.0008
Yes71 (29.83)248 (20.06)
ChemotherapyNo132 (55.46)560 (45.31)0.0040
Yes106 (44.54)676 (54.69)
RadiotherapyNo226 (94.96)1165 (94.26)0.6669
Yes12 (5.04)71 (5.74)
NEN(G/L) (median ± qrange)3.79 ± 2.533.59 ± 1.770.0526
WBC(G/L) (median ± qrange)5.80 ± 2.975.84 ± 2.230.5276
LYM(G/L) (median ± qrange)1.30 ± 0.751.55 ± 0.68<0.0001
CEA(ug/L) (median ± qrange)5.23 ± 12.403.30 ± 6.30<0.0001
CA19-9(U/ml) (median ± qrange)11.60 ± 37.108.65 ± 18.500.0201
CA125(U/ml) (median ± qrange)20.75 ± 35.1011.40 ± 8.30<0.0001
ALB(U/L) (median ± qrange)38.15 ± 6.5040.90 ± 6.10<0.0001
ALP(U/L) (median ± qrange)71.50 ± 27.0075.00 ± 27.500.0403
GGT(U/L) (median ± qrange)18.00 ± 15.0019.00 ± 13.000.8573
Tp(U/L) (median ± qrange)61.95   9.8065.30 ± 9.40<0.0001
NLR (median ± qrange)2.78 ± 2.712.28 ± 1.58<0.0001

P was calculated by the Wilcoxon test for continuous variables and the chi-square test for categorical variables. NEU, neutrophil; WBC, white blood cell; LYM, lymphocyte; CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9; CA125, cancer antigen 125; ALB, albumin; ALP, alkaline phosphatase; GGT, gamma-glutamyl transpeptidase; Tp, Total protein; NLR = neutrophil/lymphocyte.